Gene · 80310
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFRβ in Renal Fibrosis Treatment. | Biomed Res Int | 2022 | 36119923 | PubTator, text mining | PubMed |
| Molecular mechanisms for the prevention and promoting the recovery from ischemic stroke by nutraceutical laminarin: A comparative transcriptomic approach. | Front Nutr | 2022 | 36118760 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals skewed cellular communication and phenotypic shift in pulmonary artery remodeling. | JCI Insight | 2022 | 36099047 | PubTator, text mining | PubMed |
| In vivo tumor immune microenvironment phenotypes correlate with inflammation and vasculature to predict immunotherapy response. | Nat Commun | 2022 | 36085288 | PubTator, text mining | PubMed |
| KRAS Pathway Alterations in Malignant Pleural Mesothelioma: An Underestimated Player. | Cancers (Basel) | 2022 | 36077838 | PubTator, text mining | PubMed |
| Enhanced Cytotoxicity on Cancer Cells by Combinational Treatment of PARP Inhibitor and 5-Azadeoxycytidine Accompanying Distinct Transcriptional Profiles. | Cancers (Basel) | 2022 | 36077707 | PubTator, text mining | PubMed |
| Altered Adipokine Expression in Tumor Microenvironment Promotes Development of Triple Negative Breast Cancer. | Cancers (Basel) | 2022 | 36077676 | PubTator, text mining | PubMed |
| Identification of HBEGF+ fibroblasts in the remission of rheumatoid arthritis by integrating single-cell RNA sequencing datasets and bulk RNA sequencing datasets. | Arthritis Res Ther | 2022 | 36068607 | PubTator, text mining | PubMed |
| Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications. | Front Oncol | 2022 | 36059642 | PubTator, text mining | PubMed |
| Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. | Front Immunol | 2022 | 36059494 | PubTator, text mining | PubMed |
| Identification of ceRNA regulatory network in acute pancreatitis and acute recurrent pancreatitis. | Eur J Gastroenterol Hepatol | 2022 | 36052691 | PubTator, text mining | PubMed |
| Platelet-Derived Growth Factors Affect Clinical Features and Prognosis of Gastric Cancer. | J Oncol | 2022 | 36035313 | PubTator, text mining | PubMed |
| HIV-1 induction of tolerogenic dendritic cells is mediated by cellular interaction with suppressive T cells. | Front Immunol | 2022 | 36032117 | PubTator, text mining | PubMed |
| Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors. | PLoS One | 2022 | 36026497 | PubTator, text mining | PubMed |
| Adipose Tissue-Derived Mesenchymal Stromal/Stem Cells, Obesity and the Tumor Microenvironment of Breast Cancer. | Cancers (Basel) | 2022 | 36010901 | PubTator, text mining | PubMed |
| Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review. | Cells | 2022 | 36010588 | PubTator, text mining | PubMed |
| Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. | Comput Math Methods Med | 2022 | 35983531 | PubTator, text mining | PubMed |
| Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine. | Transl Oncol | 2022 | 35977458 | PubTator, text mining | PubMed |
| Inflammatory landscape in Xeroderma pigmentosum patients with cutaneous melanoma. | Sci Rep | 2022 | 35974070 | PubTator, text mining | PubMed |
| Advances of cancer-associated fibroblasts in liver cancer. | Biomark Res | 2022 | 35971182 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/80310/papers?page=16